about
Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.New antiepileptic drugs and women.Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy.Trends and changes in the clinical use of lamotrigine.Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations.Treatment non-adherence in pseudo-refractory epilepsy.Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control study.The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.Relating fatty acid composition in human fingertip blood to age, gender, nationality and n-3 supplementation in the Scandinavian population.Acute lamotrigine overdose in an adolescent.Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders.Changes in renal microcirculation induced by infusion of (Fe3+)-and (Fe2+)-myoglobin during hemorrhagic hypotension in the anesthetized rat: influence of L-NAME and 8-Br-cyclic GMPCombined overdose of atomoxetine and methylphenidate in a cytochrome P450 2D6 poor metabolizerBenzoylated uronic acid building blocks and synthesis of N-uronate conjugates of lamotrigineLamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol[Do urine tests for drugs of abuse cover the substances of interest?]Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatristsLamotrigine serum concentrations throughout the menstrual cycle--a study of 2 cases[Dosing of digitoxin in clinical practice]Nonadherence to treatment causing acute hospitalizations in people with epilepsy: an observational, prospective studyFrequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigineIn response: Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective studyIs dietary caffeine involved in seizure precipitation?[Anticonvulsants and drivers license--new guidelines should be revised]Harmonised reference ranges for antiepileptic drugsNo association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patientsMechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and PerampanelAn evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsyLamotrigine, bipolar disorder, and the pill-free week
P50
Q31152302-2885D697-6648-4887-82FB-83DB5C991287Q34423542-C542DDDF-CB40-4B28-9012-85D2383DEAC4Q34448921-212AA5FE-2D7A-4260-8AE0-EA7B62964BB0Q34557203-AF7F6586-9207-4A3D-A213-C1F90D07926AQ37044827-9422883C-AF9D-4466-AA3F-FCA8A8FBD60FQ37352974-DEAF0148-1C59-4EEF-91ED-4DFB9CBDBA6DQ38014890-183697AD-6549-4F09-BCE0-E26D1838AC59Q38406555-16FA1ECA-3C35-4965-8786-D5FBEB1FB1FAQ38742187-EB2C7BCC-DFE2-4408-B10F-8AE7E7F2B48EQ39224683-DE0FAED3-2821-485D-ACAC-A4F37DB40F97Q39602825-21C76C1A-739D-4328-AA1B-01586A539326Q45256504-ED488E01-0821-4A53-A6E0-C1EC56394A58Q46979471-26CCF8B0-946B-45CA-ABE0-F644D4B6F480Q50594549-029A3FC3-3D3F-4923-B488-8FF5C4EAF9DEQ64954197-24FCF64E-E6B4-42BC-980B-95940D192716Q71443829-447055BF-67AB-4781-9CCB-A9D2C5EDB05AQ79562807-89043603-7274-4F06-924A-0A5389905FD0Q83307216-526350D8-4663-40C5-B395-41684765D8A3Q83487636-65248DFA-974C-4BF0-BB17-51F75727050DQ83667831-65B2FC9E-1E66-43E4-876C-60812EFD355BQ83832581-79B76E78-078D-4BEE-B9EE-F54E3C17A492Q83987550-C7A56BC4-080C-4A1A-9EF7-5D01CFC5D25DQ84513146-DE36B71F-2B5F-493B-842C-80F7C1C6F89DQ85633850-694941C9-7A2B-4668-9060-E98C09073250Q86230067-0FF99391-186F-47E7-902F-451426575D33Q86349933-0D9A6DC2-B7B3-4CDE-B010-8F65A2440F96Q86918275-0D8254EF-3C14-4C45-B1D8-10260B3F7C44Q87412201-06973141-D45D-4D0C-AA1A-136C0CF82A9EQ88401267-326FEB4F-34A0-4C7B-B41E-7A6A3E5A85A3Q89485970-4A4D4BB2-AAC9-4F95-9155-11C3D8523FFAQ90729649-60FE13F9-E6CD-41D1-9AF2-2B6158A32F8BQ92595989-7FE87D81-893C-4F11-A424-969867BC937DQ92669319-6616A021-A2C2-41B8-9C4B-ED750A5C00E3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Arne Reimers
@ast
Arne Reimers
@en
Arne Reimers
@es
Arne Reimers
@nl
Arne Reimers
@sl
type
label
Arne Reimers
@ast
Arne Reimers
@en
Arne Reimers
@es
Arne Reimers
@nl
Arne Reimers
@sl
prefLabel
Arne Reimers
@ast
Arne Reimers
@en
Arne Reimers
@es
Arne Reimers
@nl
Arne Reimers
@sl
P108
P1015
P1015
P106
P108
P1153
8682692300
P21
P31
P496
0000-0002-6286-554X